(Q53509114)

15 May 2018

review article

1 reference

title

[Gastrointestinal involvement in systemic sclerosis]. (English)

1 reference

15 May 2018

author name string

Isabelle Marie

series ordinal

1

1 reference

15 May 2018

language of work or name

French

0 references

publication date

1 December 2006

1 reference

15 May 2018

published in

La Presse médicale

1 reference

15 May 2018

volume

35

1 reference

15 May 2018

issue

12 Pt 2

1 reference

15 May 2018

page(s)

1952-1965

1 reference

15 May 2018

[Digestive disorders in systemic scleroderma]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Esophageal involvement and pulmonary manifestations in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

[Pulmonary involvement in systemic scleroderma. Part I. Chronic fibrosing interstitial lung disease]

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

[Involvement of the small intestine in systemic scleroderma]

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Manometry of the upper intestinal tract in patients with systemic sclerosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastric involvement in systemic sclerosis: a prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

[Pulmonary involvement in systemic scleroderma. Part II. Isolated pulmonary arterial hypertension, bronchopulmonary cancer, alveolar hemorrhage]

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Progressive Systemic Sclerosis Sine Scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal manifestations of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal manifestations of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal motility disorders in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal manifestations of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Systemic scleroderma: A review of organ systems

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Predictors of survival in systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Mortality and causes of death in a Swedish series of systemic sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Abnormal postcibal antral and small bowel motility due to neuropathy or myopathy in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Sequential dermal microvascular and perivascular changes in the development of scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Superior mesenteric artery blood flow in systemic sclerosis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Duodenal myoelectric activity in scleroderma. Abnormal responses to mechanical and hormonal stimuli.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

SCLERODERMA OF THE ESOPHAGUS. A CORRELATION OF HISTOLOGIC AND PHYSIOLOGIC FINDINGS

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Oesophageal pressure-cross-sectional area distributions and secondary peristalsis in relation to subclassification of systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Primary biliary cirrhosis with scleroderma, Raynaud's phenomenon and telangiectasia. New syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

An unusual presentation of pill-induced esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Barrett's esophagus in scleroderma: Increased prevalence and radiographic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Watermelon stomach and systemic sclerosis: localization of digestive system involvement?

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Treatment of GI dysmotility in scleroderma with the new enterokinetic agent prucalopride

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Evidence of omeprazole-induced small bowel bacterial overgrowth in patients with scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Malabsorption caused by coeliac disease in patients who have scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Intestinal atony in progressive systemic sclerosis (scleroderma)

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Systemic sclerosis and small bowel involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Pneumatosis cystoides intestinalis. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Pneumatosis cystoides intestinalis in systemic sclerosis and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Spontaneous perforation of the small intestine due to scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Small-bowel volvulus in association with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Nutritional support in patients with systemic scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Intestinal perforation associated with octreotide therapy in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Free intra-abdominal gas associated with octreotide use: intestinal perforation or benign pneumoperitoneum associated with underlying systemic sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Home central venous hyperalimentation in fifteen patients with severe scleroderma bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Bowel problems in patients with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Subtotal colectomy and cecosigmoid anastomosis for colonic systemic sclerosis: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

The watermelon rectum

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Comparative esophageal and anorectal motility in scleroderma

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Progressive systemic sclerosis of the internal anal sphincter leading to passive faecal incontinence

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Sacral nerve stimulation for faecal incontinence due to systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Scleroderma and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

THE CLINICAL SIGNIFICANCE OF THE ANTICENTROMERE ANTIBODY

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

Exocrine pancreatic function in patients with progressive systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0755-4982%2806%2974930-2

7 January 2021

10.1016/S0755-4982(06)74930-2

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17159722

1 reference

15 May 2018